Leming Pharmaceuticals is a pharmaceutical enterprise founded in 2019, with a focus on R&D, production, and sales of innovative pharmaceutical preparations. The company's dedication to research, production, and distribution is captured in its slogan: "A pharmaceutical enterprise dedicated to the research, production, and distribution of innovative medicinal preparations." In June 2024, the company secured a substantial CNY100.00M Venture Round investment from Fuho Capital, Ruihe Capital, Sinopharm-CICC, and Chengming Capital. This investment is indicative of the confidence that prominent investors have in Leming Pharmaceuticals' vision and potential within the pharmaceutical industry. With this recent investment, Leming Pharmaceuticals is poised to reinforce its position as a key player in the pharmaceutical market with its innovative medicinal offerings.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | CNY100.00M | 4 | Sinopharm-CICC, Chengming Capital | 07 Jun 2024 |
Series A | Unknown | 3 | Wuzhong Luduan Jinmiao Science and Technology Innovation Fund | 14 Apr 2023 |
Seed Round | Unknown | 2 | Shandong Transportation Industry Development Fund, Meba Capital | 17 Sep 2021 |
No recent news or press coverage available for Leming Pharmaceuticals.